• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢替安在人体中的药代动力学。

Pharmacokinetics of cefotiam in humans.

作者信息

Rouan M C, Lecaillon J B, Guibert J, Modai J, Schoeller J P

出版信息

Antimicrob Agents Chemother. 1985 Feb;27(2):177-80. doi: 10.1128/AAC.27.2.177.

DOI:10.1128/AAC.27.2.177
PMID:3857018
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC176233/
Abstract

After intravenous bolus injections of 0.5, 1, and 2 g of cefotiam to three healthy volunteers, the mean (+/- standard deviation) total plasma clearances measured for each dose were, respectively, 26.8 +/- 2.7, 22.8 +/- 0.8, and 17.8 +/- 0.9 liters/h; the terminal elimination half-lives were 54.0 +/- 0.1, 68 +/- 15, and 98 +/- 36 min; and the renal clearances were 16.0 +/- 2.9, 13.3 +/- 1.4, and 11.3 +/- 2.6 liters/h. The 24-h urinary recovery was independent of the dose and averaged 53% of the dose. After intramuscular administration of 1 g of cefotiam to three healthy volunteers, a mean (+/- standard deviation) peak concentration of 16.6 +/- 5.1 micrograms/ml was reached at 0.75 to 1 h post dosing. The concurrent intramuscular administration of lidocaine and cefotiam did not modify the kinetics of cefotiam. During a constant-rate infusion, the steady-state plasma clearance decreased slightly when the infusion rate was increased. There was no trend towards accumulation of cefotiam in plasma during chronic treatment with 1 g intravenously every 12 h for 10 days.

摘要

对三名健康志愿者静脉推注0.5克、1克和2克头孢替安后,各剂量测得的平均(±标准差)总血浆清除率分别为26.8±2.7、22.8±0.8和17.8±0.9升/小时;终末消除半衰期分别为54.0±0.1、68±15和98±36分钟;肾清除率分别为16.0±2.9、13.3±1.4和11.3±2.6升/小时。24小时尿液回收率与剂量无关,平均为剂量的53%。对三名健康志愿者肌肉注射1克头孢替安后,给药后0.75至1小时达到的平均(±标准差)峰值浓度为16.6±5.1微克/毫升。同时肌肉注射利多卡因和头孢替安并未改变头孢替安的动力学。在恒速输注期间,当输注速率增加时,稳态血浆清除率略有下降。每12小时静脉注射1克,持续10天进行慢性治疗期间,血浆中头孢替安没有蓄积趋势。

相似文献

1
Pharmacokinetics of cefotiam in humans.头孢替安在人体中的药代动力学。
Antimicrob Agents Chemother. 1985 Feb;27(2):177-80. doi: 10.1128/AAC.27.2.177.
2
Pharmacokinetics of cefotiam administered intravenously and intramuscularly to healthy adults.头孢替安对健康成年人静脉注射和肌肉注射的药代动力学。
Antimicrob Agents Chemother. 1984 Oct;26(4):513-8. doi: 10.1128/AAC.26.4.513.
3
Pharmacokinetics of cefotiam in normal humans.
Antimicrob Agents Chemother. 1982 Dec;22(6):958-60. doi: 10.1128/AAC.22.6.958.
4
Pharmacokinetics and dosage adjustment of cefotiam in renal impaired patients.肾功能不全患者中头孢替安的药代动力学及剂量调整
J Antimicrob Chemother. 1984 Jun;13(6):611-8. doi: 10.1093/jac/13.6.611.
5
Pharmacokinetics of cefotiam in patients with impaired renal function and in those undergoing hemodialysis.头孢替安在肾功能不全患者及血液透析患者中的药代动力学。
Antimicrob Agents Chemother. 1984 Nov;26(5):647-51. doi: 10.1128/AAC.26.5.647.
6
Pharmacokinetics and quantitative characterization of cefotiam excretion after intravenous administration to patients after cholecystectomy.
Eur J Clin Pharmacol. 1986;30(4):439-44. doi: 10.1007/BF00607957.
7
Plasma and skin blister fluid levels of cefotiam and cefmenoxime after single intramuscular application of 1 g in gonorrhea.单次肌内注射1g头孢替安和头孢甲肟治疗淋病后血浆及皮肤水疱液中的药物水平
Chemotherapy. 1984;30(5):277-82. doi: 10.1159/000238281.
8
Single-dose pharmacokinetics of ceftriaxone in healthy Chinese adults.头孢曲松在中国健康成年人中的单剂量药代动力学。
Antimicrob Agents Chemother. 1985 Feb;27(2):192-6. doi: 10.1128/AAC.27.2.192.
9
[Pharmacokinetic and clinical studies of cefotiam in mature neonates].
Jpn J Antibiot. 1986 Sep;39(9):2450-7.
10
Pharmacokinetic study of cefmenoxime (SCE 1365-CMX) in healthy adults.头孢甲肟(SCE 1365-CMX)在健康成年人中的药代动力学研究。
Am J Med. 1984 Dec 21;77(6A):28-31. doi: 10.1016/s0002-9343(84)80071-6.

引用本文的文献

1
Novel Population Pharmacokinetic Approach to Explain the Differences between Cystic Fibrosis Patients and Healthy Volunteers via Protein Binding.通过蛋白质结合解释囊性纤维化患者与健康志愿者差异的新型群体药代动力学方法。
Pharmaceutics. 2019 Jun 18;11(6):286. doi: 10.3390/pharmaceutics11060286.
2
Clinical pharmacokinetics of newer cephalosporins.新型头孢菌素的临床药代动力学
Clin Pharmacokinet. 1995 May;28(5):361-84. doi: 10.2165/00003088-199528050-00003.
3
Cefotiam disposition in markedly obese athlete patients, Japanese sumo wrestlers.头孢替安在极度肥胖运动员患者(日本相扑摔跤手)中的处置情况。
Antimicrob Agents Chemother. 1989 Aug;33(8):1188-92. doi: 10.1128/AAC.33.8.1188.

本文引用的文献

1
Cefoperazone and cefotiam--two new cephalosporins: an in-vitro comparison.
J Antimicrob Chemother. 1981 Apr;7(4):343-52. doi: 10.1093/jac/7.4.343.
2
Pharmacokinetics of cefotiam in normal humans.
Antimicrob Agents Chemother. 1982 Dec;22(6):958-60. doi: 10.1128/AAC.22.6.958.
3
Determination of cefsulodin, cefotiam, cephalexin, cefotaxime, desacetyl-cefotaxime, cefuroxime and cefroxadin in plasma and urine by high-performance liquid chromatography.高效液相色谱法测定血浆和尿液中的磺苄西林、头孢替安、头孢氨苄、头孢噻肟、去乙酰头孢噻肟、头孢呋辛和头孢拉定。
J Chromatogr. 1982 Mar 12;228:257-67. doi: 10.1016/s0378-4347(00)80438-7.
4
Pharmacokinetics and dosage adjustment of cefotiam in renal impaired patients.肾功能不全患者中头孢替安的药代动力学及剂量调整
J Antimicrob Chemother. 1984 Jun;13(6):611-8. doi: 10.1093/jac/13.6.611.
5
SCE-963, a new broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities.SCE - 963,一种新型广谱头孢菌素:体外及体内抗菌活性
Antimicrob Agents Chemother. 1978 Oct;14(4):557-68. doi: 10.1128/AAC.14.4.557.